Report Highlights
-
Sales of imaging equipment, for which the U.S. market is projected to reach $6.1 billion in 2002, are expected to grow at a 3.4% AAGR, reaching $7.2 billion (in 2002 dollars) by 2007.
-
The imaging products whose sales are expected to grow most rapidly include digital radiography units, multislice CT scanners, open and ultra- high-field MRI, multimodal CT/PET scanners, and ultrasound, especially portable ultrasound units.
-
The clinical use of PET (positron emission tomography) and the installed base of dedicated PET scanners will also increase dramatically over the forecast period, although the sales expansion of the last few years is expected to moderate.
-
The fastest-growing category of the imaging market consists of computer systems that are used as adjuncts to imaging equipment.
INTRODUCTION
When Wilhelm Roentgen waved his hand through a stream of X-rays and saw his bones silhouetted on a screen across the room, he began a new era in medicine: for the first time, physicians could see into the hidden recesses of the body. In the century following Roentgen's accidental discovery, X-ray was followed by a variety of different methods of imaging body tissues, such as ultrasound, nuclear medicine, computed tomography and magnetic resonance imaging.
Today, imaging devices reveal every organ and lay bare every disease. They show us three-dimensional, full-color pictures of the beating heart and cross-sectional slices of the abdomen. We can see blood flowing through our arteries, water traveling along nerve fibers, cells dying in a tumor, antibodies battling infection, and, strangest of all, emotions such as fear and love arising in the brain.
These devices even analyze the images they produce;they identify malignancies, count plaque deposits in arteries, measure bone loss, and calculate the heart's pumping capacity. They also assist surgeons, tracking the positions of their instruments in real time and letting them know what their scalpels are about to cut into.
None of these advances occurred in a vacuum. The newest generation of imaging devices is based on breakthroughs in computer technology, materials science, molecular biology, and medical science. The medical imaging industry works with medical researchers, pharmaceutical companies, and others, to design equipment that will help physicians diagnose and treat disease.
In today's advanced systems, computers optimize equipment settings and then construct, enhance and analyze the images. Even simple X-ray devices are giving way to digital systems in which computer screens replace film. Digital picture archiving and communications systems (PACS) are replacing film libraries and couriers, and helping radiologists to work more effectively. For the accident victim in an emergency room, instant delivery of images to the radiologist may save a life.
Molecular biology is also transforming imaging. The newest contrast agents are complex "designer drugs", based on biological research. They can target and report_highlights precise locations on cells in order to answer highly specific questions. The findings of the Human Genome Project have opened up a world of possibilities for molecular imaging. Equipment designers are learning to optimize their devices to take advantage of these new contrast agents.
Researchers are also developing new techniques for using imaging equipment-techniques that allow radiologists to devise new diagnostic tests, or perform older tests on hard-to-image patients. Again, manufacturers are fine-tuning their equipment so they can use the new techniques.
Over the last few years, the industry has seen a wave of consolidations and joint ventures as large firms diversified their product lines. Now that the leading firms all offer a complete range of imaging systems, they have begun to combine modalities in novel ways. Some of the new hybrid devices create fused images that superimpose two different views of the same subject. Others can be used in different modes to produce different varieties of images.
SCOPE OF STUDY
This report focuses provides coverage of:
- the modalities generally considered part of the medical imaging industry, including Xray, computed tomography, magnetic resonance imaging, ultrasound and nuclear medicine
- newer imaging modalities such as electrical impedance scanning and optical coherence tomography
- medical imaging markets for each type of product and application, and for geographical areas of the world, with forecasts through 2007
- leading companies in the industry and the structure of the industry
- the regulatory environment, and salient technological developments in each area.
METHODOLOGY
We employed statistical forecasting techniques along with considering developments in technology and other factors affecting demand for equipment. These factors are discussed in each forecast section of the report. Other published forecasts were considered and critically assessed. All projections are in 2002 constant dollars.
INFORMATION SOURCES
To research this report, we reviewed data published by government agencies and industry and professional associations; vendors' annual reports, regulatory submissions, press releases and product literature; healthcare providers' annual reports, web sites and published purchasing plans; and secondary information such as articles in scientific, medical and industry journals. Information and analysis was also obtained through direct discussion or correspondence with manufacturers, healthcare providers, government agencies, and industry and professional associations.
AUTHOR'S CREDENTIALS
Masha Zager is a writer specializing in and technology. Trained as an economist, she has written about information technology, telecommunications, call center technology, energy markets, securities markets, municipal finance, and a wide variety of other subjects.
Related Reports
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Healthcare Fraud Detection Market
This report provides a brief general outlook of the global healthcare fraud detection market. It includes global revenue ($ million) for base year data of 2024, estimated data of 2025, and forecasts through 2030. The report focuses on the significant driving trends and challenges that affect the global market and its vendor landscape.
Global Orthopedic Surgical Robots Market
The global market for orthopedic surgical robots was valued at $2.7 billion in 2025 and is expected to reach $4.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2030.
Chronic Kidney Disease: Global Markets and Technologies
The global market for chronic kidney disease was valued at $52.9 billion in 2025 and is estimated to reach $82.6 billion by 2030, at a compound annual growth rate (CAGR) of 9.3% from 2025 through 2030.
State of the Life Sciences Industry - 2026 First Quarter Review
Explore BCC Research’s Q1 2026 review of the life sciences industry, covering market trends, innovation, sector performance, and growth outlook.
Noninvasive Cancer Diagnostics: Technologies and Global Markets
The global market for noninvasive cancer diagnostic technologies is expected to grow from $119.9 billion in 2025 and is projected to reach $165.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2025 to 2030.
Top Trending Reports
2025 Medical Devices Research Review
Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.
Cancer Profiling and Pathways: Technologies and Global Markets
The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Glass Fiber: Global Markets
The global market for glass fiber is expected to grow from $13.5 billion in 2026 and is projected to reach $17.2 billion by the end of 2031, at a compound annual growth rate (CAGR) of 4.9% during the forecast period of 2026 to 2031.
2025 Chemical Research Review
BCC Research’s 2025 Chemical Research Review covering market trends, specialty chemicals, industrial innovation and growth opportunities across the chemical industry.
Report Highlights
-
The U.S. diagnostic imaging is a growing multibillion market. The total market is growing at an average annual growth rate (AAGR) of 5.9% through 2004. Valued at just over $4 billion in 1999, diagnostic imaging will generate nearly $5.4 billion by the 2004.
-
X-ray systems dominate the market in terms of growth and revenue, growing at an AAGR of 7.8% and garnering a 47.7% share. Digital systems, a relatively small fraction of the X-ray systems market, are nonetheless on pace to eventually replace older equipment. These systems alone are experiencing market growth of nearly 23% per year on average. By 2004, X-ray systems will account for 52.1% of the market for diagnostic imaging equipment.
-
CT, Ultrasound, and nuclear medicine systems, while experiencing sales growth, are not expected to keep pace. Together, CT and Ultrasound systems will grow at an AAGR of 4.1% through the period, while systems for nuclear medicine will grow at an average annual rate of only 3.4%.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More